Citations

Mayo Clinic

Showing 10 of 108599 citations.

Prognostic and predictive significance of thymidylate synthase protein expression in non-small cell lung cancer: A systematic review and meta-analysis
Liu, Qingyun , Yu, Zubin, Xiang, Ying , Wu, Long , Xu, Bin , Li, Yafei , Bai, Li , Wu, Na , Wang, Liang , Yang, Ping

Cancer Biomarkers | January 31, 2017 | Volume: 15 | Issue: 1 | Pages: 65-78

10.3233/cbm-140432 | PMID 25524944 Get It

Exploratory study of a KLK2 polymorphism as a prognostic marker in prostate cancer
Kohli, Manish , Rothberg, Paul G., Feng, Changyong , Messing, Edward M. , Joseph, Jean, Rao, Sreevidya Sadasiva, Hendershot, Allison , Sahsrabudhe, Deepak, Kohli, Manish

Cancer Biomarkers | January 31, 2017 | Volume: 7 | Issue: 2 | Pages: 101-108

10.3233/cbm-2010-0152 | PMID 21178268 Get It

Antibodies in cancer immunotherapy
Karyampudi, Lavakumar, Knutson, Keith L. , Knutson, Keith L.

Cancer Biomarkers | January 31, 2017 | Volume: 6 | Issue: 5-6 | Pages: 291-305

10.3233/cbm-2009-0141 | PMID 20938089 Get It

Workshop on imaging science development for cancer prevention and preemption
Kelloff, Gary J. , Sullivan, Daniel C. , Baker, Houston, Clarke, Lawrence, Nordstrom, Robert J. , Tatum, James L. , Dorfman, Gary S., Berg, Christine D. , Birrer, Michael J. , Tempero, Margaret A. , Higley, Howard R., Petty, Brenda Gumbs, Sigman, Caroline C. , Ginsberg, Gregory G. , Dannenberg, Andrew J. , Hawk, Ernest T. , Messing, Edward M. , Grossman, H. Barton, Griebel, Donna, Henson, Donald E., Fabian, Carol J. , Zujewski, Jo Anne , Hayes, Wendy, Klein, Eric A. , Ocak, İclal , Tempany, Clare M. , Shtern, Faina, Parnes, Howard L. , Gómez, Jorge , Srivastava, Sudhir , Lam, Stephen , Seibel, Eric J. , Massion, Pierre P. , McLennan, Geoffrey, Burt, Randall W., Hoffman, John M. , El‐Deiry, Wafik S. , Papadimitrakopoulou, Vali, Veltri, Robert W., Solomon, Diane, Viner, Jaye L., Stratton, Steven P. , Rajadhyaksha, Milind , Dhawan, Atam P. , Jacobs, Paula , Pomper, Martin G. , Maley, Carlo C. , Sharma, Prateek , Wax, Adam , Harisinghani, Mukesh G. , Bigio, Irving J. , Ferrara, Katherine W. , Fantini, Sergio , Schnall, Mitchell D. , Zujewski, Jo Anne , Marzo, Angelo M. De , Ketterling, Jeffrey A. , Szabó, Éva , Cleary, Kevin , Suh, Robert D. , Pfeiffer, Ruth M. , Roy, Hemant K. , Wang, Thomas J. , Limburg, Paul J. , Hittelman, Walter N. , MacAulay, Calum E. , Jerónimo, José , Richards‐Kortum, Rebecca , Johnson, Karen A. , Klein, Eric A

Cancer Biomarkers | January 31, 2017 | Volume: 3 | Issue: 1 | Pages: 1-33

10.3233/cbm-2007-3101 | PMID 17655039 Get It

Ascending the learning curve – MSI testing experience of a six-laboratory consortium
Lindor, Noralane M. , Smalley, Regenia L., Barker, Melissa, Bigler, Jeannette, Krumroy, Lisa M., Lum‐Jones, Annette, Plummer, Sarah J. , Selander, Teresa, Thomas, Sushma , Youash, Michelle, Seminara, Daniela, Bapat, Bharati , Thibodeau, Stephen N. , Casey, Graham

Cancer Biomarkers | January 31, 2017 | Volume: 2 | Issue: 1-2 | Pages: 5-9

10.3233/cbm-2006-21-202 | PMID 17192055 Get It

Surveillance for liver complications after the Fontan procedure
Hilscher, Moira , Johnson, Jonathan N. , Cetta, Frank , Driscoll, David J. , Poterucha, John J., Sánchez, William , Connolly, Heidi M. , Kamath, Patrick S. , Hilscher, Moira B, Sanchez, William

Congenital Heart Disease | January 31, 2017 | Volume: 12 | Issue: 2 | Pages: 124-132

10.1111/chd.12446 | PMID 28140526 Get It

Human Gongylonema pulchrum Infection: Esophageal Symptoms and Need for Prolonged Albendazole Therapy
Reza, Mohammed, Peterson, Joy H., Hata, D. Jane , Libertin, Claudia R. , Lewis, Jason

The American Society of Tropical Medicine and Hygiene | January 31, 2017 | Volume: 96 | Issue: 4 | Pages: 873-875

10.4269/ajtmh.16-0852 | PMID 28138043 Get It

We describe a case of human infection with Gongylonema pulchrum acquired in southeast Georgia. The patient presented with intermittent yet persistent nausea and vomiting for months. This case describes the need for extraction of worms on two occasions each followed by courses of albendazole treatment. Gongylonema pulchrum infections with high worm burden may relapse after extraction of the worm and a 3-day short course of albendazole therapy. Longer courses of albendazole may be indicated in selected circumstances.
GEL THE NEC: a prospective registry evaluating the safety, ease of use, and efficacy of the HydroSoft coil as a finishing device
Brinjikji, Waleed , Amar, Arun Paul , Almandoz, Josser E Delgado , Díaz, Orlando , Jabbour, Pascal , Kelly, Michael , Layton, Kennith D, Miller, Jeffrey W. , Levy, Elad, Moran, Christopher J. , Woo, Henry H. , Sellar, Robin, Ho, Brian , Evans, Avery J. , Kallmes, David F. , Suh, Dae C , Jabbour, Pascal , Hanel, Ricardó A. , Hui, Ferdinand , Levy, E, Ho, Brian, Miller, Jeffrey

Journal of NeuroInterventional Surgery | January 30, 2017 | Volume: 10 | Issue: 1 | Pages: 83-87

10.1136/neurintsurg-2016-012915 | PMID 28138062 Get It

Background and purpose The HydroSoft coil was developed as a finishing coil, ideally to be placed along the aneurysm neck to enhance intracranial aneurysm healing. The GEL THE NEC (Gaining Efficacy Long Term: Hydrosoft, an Emerging, New, Embolic Coil) multicenter registry was developed to assess the safety and efficacy of HydroSoft coils in treating intracranial aneurysms. We report angiographic and clinical results of this prospective registry. Materials and methods GEL THE NEC was performed at 27 centers in five countries. Patients aged 21–90 years with a ruptured or unruptured aneurysm 3–15 mm in size were eligible for enrollment. The following variables were obtained: demographics/comorbidities, aneurysm geometry, adjunctive devices used, proportion of patients in whom HydroSoft coils were successfully placed, and long-term angiographic outcomes (graded by an independent core laboratory using the Modified Raymond Scale), and procedure-related adverse events. Predictors of good angiographic outcome were studied using χ2 and t-tests. Results A total of 599 patients with 599 aneurysms were included in this study. HydroSoft coils were successfully deployed in 577 (96.4%) patients. Procedure-related major morbidity and mortality were 0.5% (3/599) and 1.3% (8/599), respectively. The most common perioperative complications were iatrogenic vasospasm (30/599, 5.0%), thromboemboli (27/599, 4.5%), and aneurysm perforation (16/599, 2.7%). At last angiographic follow-up (mean 9.0±6.3 months), the complete occlusion rate was 63.2% (280/442) and near complete occlusion rate was 25.2% (107/442). The core laboratory read recanalization rate was 10.8% (46/425) and the retreatment rate was 3.4% (20/599). Conclusions Endovascular treatment of intracranial aneurysms with HydroSoft coils resulted in complete/near complete occlusion rates of 88% and a major complication rate of 1.8%. Trial registration number NCT01000675.
Association Between Mentally Stimulating Activities in Late Life and the Outcome of Incident Mild Cognitive Impairment, With an Analysis of the APOE ε4 Genotype
Vemuri, Prashanthi , Pink, Anna , Roberts, Rosebud O., Stokin, Gorazd B. , Mielke, Michelle M. , Christianson, Teresa J., Petersen, Ronald C. , Kremers, Walter K. , Geda, Yonas E. , Krell-Roesch, Janina, Christianson, Teresa J H, Krell‐Roesch, Janina , Knopman, David S. , Mielke, Michelle M , Vemuri, Prashanthi , Geda, Yonas E , Stokin, Gorazd , Kremers, Walter K

JAMA Neurology | January 30, 2017 | Volume: 74 | Issue: 3 | Pages: 332

10.1001/jamaneurol.2016.3822 | PMID 28135351 Get It

Malignant Catatonia Warrants Early Psychiatric-Critical Care Collaborative Management: Two Cases and Literature Review
Park, Julia , Tan, Josh, Krzeminski, Sylvia, Hazegh-Azam, Maryam, Bandlamuri, Meghana, Carlson, Richard W, Carlson, Richard W.

Case Reports in Critical Care | January 30, 2017 | Volume: 2017 | Issue: No issue available | Pages: 1-4

10.1155/2017/1951965 | PMID 28250995 Get It

Malignant catatonia (MC) is a life-threatening manifestation which can occur in the setting of an underlying neuropsychiatric syndrome or general medical illness and shares clinical and pathophysiological features and medical comorbidities with the Neuroleptic Malignant Syndrome (NMS). The subsequent diagnosis and definitive therapy of MC are typically delayed, which increases morbidity and mortality. We present two cases of MC and review recent literature of MC and NMS, illustrating factors which delay diagnosis and management. When clinical features suggest MC or NMS, we propose early critical care consultation and stabilization with collaborative psychiatric management.